plasma exchange

  1. forestglip

    Preprint Feasibility and outcomes of crossflow membrane plasmapheresis for long COVID in Suriname: [placebo-controlled DBRCT], 2026, Bihariesingh-Sanchit et al

    Feasibility and outcomes of crossflow membrane plasmapheresis for long COVID in Suriname: a randomized double-blind placebo-controlled pilot trial Background Long COVID is heterogeneous and currently without cure. The disease resembles myalgic encephalomyelitis/chronic fatigue syndrome...
  2. forestglip

    [ME/CFS]: Successful Therapeutic Plasma Exchange Treatment After SARS‐CoV‐2 Infection—A Case Report, 2026, Ciobanu et al

    Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Successful Therapeutic Plasma Exchange Treatment After SARS‐CoV‐2 Infection—A Case Report Ciobanu, Georgiana; Arn, Norbert Abstract Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex neuroimmunological disorder...
  3. SNT Gatchaman

    Trial Report Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial, 2025, España-Cueto+

    Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial España-Cueto, Sergio; Loste, Cora; Lladós, Gemma; López, Cristina; Santos, José Ramón; Dulsat, Gemma; García, Anna; Carmezim, João; Carabia, Julia; Ancochea, Águeda...
  4. Trish

    'The dementia that can be cured' - Guardian article about autoimmune neurological diseases, 2020

    https://www.theguardian.com/science/2020/oct/25/the-dementia-that-can-be-cured The dementia that can be cured Treatments mentioned include steroids, rituximab and plasma exchange.
Back
Top Bottom